{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:12:47Z","timestamp":1789398767312,"version":"build-2803163510"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Little is known about viral-associated hemophagocytic lymphohistiocytosis (HLH) in Oman. This study was done to assess the epidemiology, clinical features and outcome of viral-associated HLH in our setting.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We retrospectively reviewed children (0\u201318 years) managed for viral-associated HLH at the Sultan Qaboos University Hospital, Oman, over a 15-year period (2006\u20132020). Patients\u2019 medical records were used to describe their demographic, clinical and laboratory features, management and outcome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Fifty-six children were managed for HLH at Sultan Qaboos University Hospital over the last 15 years (2006\u20132020) of whom a third (19; 34%) had a viral trigger. The median age at the time of diagnosis of viral-associated HLH was 83 (13\u201396) months. Fever, cytopenia, hyperferritinemia and evidence of hemophagocytosis in bone marrow were the most consistent findings. Most of these children had either genetic predisposition to HLH (8\/19; 42%) or underlying immunodeficiency secondary to malignant conditions or chemotherapy\/hematopoietic stem cell transplantation (6\/19; 32%). Epstein-Barr virus (9; 47%) followed by cytomegalovirus (6; 31%) was the most common viral trigger in our setting. Treatment included antivirals (8; 42%), HLH 2004 protocol (4; 21%), rituximab (4; 21%) and hematopoietic stem cell transplantation (3; 16%). Fourteen children (74%) had full recovery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In our small cohort, viral-associated HLH was more frequently encountered in children with genetic predisposition to HLH or children with underlying immunodeficiency. In addition, we found that the outcome is overall good for children who have no genetic predisposition to HLH and children with genetic predisposition who underwent hematopoietic stem cell transplantation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003401","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T06:02:34Z","timestamp":1638252154000},"page":"330-334","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Outcome of Viral-associated Hemophagocytic Lymphohistiocytosis at a Tertiary Hospital"],"prefix":"10.1097","volume":"41","author":[{"given":"Hanan F.","family":"Nazir","sequence":"first","affiliation":[{"name":"Child Health Department, Sultan Qaboos University Hospital, Muscat, Oman"},{"name":"Department of Pediatrics, Alexandria Faculty of Medicine, Alexandria, Egypt."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehad","family":"Hassanein","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Alexandria Faculty of Medicine, Alexandria, Egypt."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser","family":"Wali","sequence":"additional","affiliation":[{"name":"Child Health Department, Sultan Qaboos University Hospital, Muscat, Oman"},{"name":"Department of Pediatrics, Alexandria Faculty of Medicine, Alexandria, Egypt."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila S.","family":"Al Yazidi","sequence":"additional","affiliation":[{"name":"Child Health Department, Sultan Qaboos University Hospital, Muscat, Oman"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,11,26]]},"reference":[{"key":"R1-20250615","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fped.2016.00047","article-title":"Hemophagocytic lymphohistiocytosis in children: pathogenesis and treatment.","volume":"4","author":"Ishii","year":"2016","journal-title":"Front Pediatr"},{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S1473-3099(07)70290-6","article-title":"Infections associated with haemophagocytic syndrome.","volume":"7","author":"Rouphael","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"R3-20250615","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s12098-020-03190-6","article-title":"Hemophagocytic lymphohistiocytosis in children.","volume":"87","author":"Nandhakumar","year":"2020","journal-title":"Indian J Pediatr"},{"key":"R4-20250615","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3201\/eid0606.000608","article-title":"Hemophagocytic syndromes and infection.","volume":"6","author":"Fisman","year":"2000","journal-title":"Emerg Infect Dis"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/eji.201646686","article-title":"Primary and secondary hemophagocytic lymphohistiocytosis have different patterns of T-cell activation, differentiation and repertoire.","volume":"47","author":"Ammann","year":"2017","journal-title":"Eur J Immunol"},{"key":"R6-20250615","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12916-020-01682-y","article-title":"Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?","volume":"18","author":"Opoka-Winiarska","year":"2020","journal-title":"BMC Med"},{"issue":"suppl 1","key":"R7-20250615","first-page":"583","article-title":"Familial hemophagocytic lymphohistiocytosis in Oman: an update on unique clinical and molecular features.","volume":"101","author":"Elshinawy","year":"2016","journal-title":"Haematologica"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1182\/asheducation-2011.1.178","article-title":"Approach to hemophagocytic syndromes.","volume":"2011","author":"Weitzman","year":"2011","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1182\/blood-2011-08-374199","article-title":"A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes.","volume":"119","author":"Bryceson","year":"2012","journal-title":"Blood"},{"key":"R11-20250615","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/JBM.S46255","article-title":"Hemophagocytic lymphohistiocytosis: review of etiologies and management.","volume":"5","author":"George","year":"2014","journal-title":"J Blood Med"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1532\/IJH97.07012","article-title":"Nationwide survey of hemophagocytic lymphohistiocytosis in Japan.","volume":"86","author":"Ishii","year":"2007","journal-title":"Int J Hematol"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/1097-0142(197909)44:3<993::AID-CNCR2820440329>3.0.CO;2-5","article-title":"Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis.","volume":"44","author":"Risdall","year":"1979","journal-title":"Cancer"},{"key":"R14-20250615","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/bjh.13462","article-title":"Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents.","volume":"170","author":"Lehmberg","year":"2015","journal-title":"Br J Haematol"},{"key":"R15-20250615","first-page":"207","article-title":"Malignancy-associated hemophagocytic lymphohistiocytosis in pediatric cases: a multicenter study from Turkey.","volume":"51","author":"Celkan","year":"2009","journal-title":"Turk J Pediatr"},{"key":"R16-20250615","first-page":"997","article-title":"Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies.","volume":"100","author":"Lehmberg","year":"2015","journal-title":"Haematologica"},{"key":"R17-20250615","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-219057","article-title":"Haemophagocytic lymphohistiocytosis as a consequence of untreated B-cell chronic lymphocytic leukaemia.","volume":"2017","author":"Bailey","year":"2017","journal-title":"BMJ Case Rep"},{"key":"R18-20250615","doi-asserted-by":"crossref","first-page":"bcr","DOI":"10.1136\/bcr-2018-225592","article-title":"Cytomegalovirus-associated haemophagocytic lymphohistiocytosis: a rare cause of febrile neutropenia during cancer chemotherapy.","volume":"2018","author":"Bergmann","year":"2018","journal-title":"BMJ Case Rep"},{"key":"R19-20250615","first-page":"326053","article-title":"A case of hemophagocytic lymphohistiocytosis in a patient with chronic lymphocytic leukemia after treatment with fludarabine, cyclophosphamide, and rituximab chemotherapy, with autopsy findings.","volume":"2012","author":"Tiong","year":"2012","journal-title":"Case Rep Hematol"},{"key":"R20-20250615","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1440-1754.2006.00879.x","article-title":"Successful treatment of cytomegalovirus-associated haemophagocytic syndrome following paediatric orthotopic liver transplantation.","volume":"42","author":"Hardikar","year":"2006","journal-title":"J Paediatr Child Health"},{"key":"R21-20250615","doi-asserted-by":"crossref","first-page":"S262","DOI":"10.1016\/j.bbmt.2015.11.695","article-title":"Hemophagocytic lymphohistiocytosis (HLH) after hematopoietic stem cell transplant (HSCT) or an impostor: a word of caution!","volume":"22","author":"Vatsayan","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"R22-20250615","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/08880018.2011.601402","article-title":"Secondary hemophagocytosis in 3 patients with organic acidemia involving propionate metabolism.","volume":"29","author":"Gokce","year":"2012","journal-title":"Pediatr Hematol Oncol"},{"key":"R23-20250615","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1542\/peds.65.5.1023","article-title":"The pancytopenia of isovaleric acidemia.","volume":"65","author":"Kelleher","year":"1980","journal-title":"Pediatrics"},{"key":"R24-20250615","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/s10875-017-0443-1","article-title":"Effective immunological guidance of genetic analyses including exome sequencing in patients evaluated for hemophagocytic lymphohistiocytosis.","volume":"37","author":"Ammann","year":"2017","journal-title":"J Clin Immunol"},{"key":"R25-20250615","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/bjh.15274","article-title":"How i treat primary haemophagocytic lymphohistiocytosis.","volume":"182","author":"Marsh","year":"2018","journal-title":"Br J Haematol"},{"key":"R26-20250615","first-page":"183","article-title":"Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.","volume":"89","author":"Imashuku","year":"2004","journal-title":"Haematologica"},{"key":"R27-20250615","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1097\/INF.0000000000002248","article-title":"Hemophagocytic lymphohistiocytosis and infections: an update.","volume":"38","author":"Chesshyre","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"R28-20250615","doi-asserted-by":"crossref","first-page":"100527","DOI":"10.1016\/j.eclinm.2020.100527","article-title":"Multisystem inflammatory syndrome in children: a systematic review.","volume":"26","author":"Ahmed","year":"2020","journal-title":"EClinicalMedicine"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003401","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:03:48Z","timestamp":1750003428000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,26]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003401","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,26]]}}}